Clinical trial

A Study of HDM1005 in Participants With Type 2 Diabetes Not Controlled With Diet and Exercise Alone

NCT07394114

StatusRECRUITING

Study typeINTERVENTIONAL

Start date2026-02-24

PhasePHASE3

Study timeline

Study start (estimated)2026-02-24Date precision: day

Registry last updated2026-02-09

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Type 2 Diabetesunresolved

Interventions

HDM1005 1DRUG

HDM1005 2DRUG

HDM1005 injection or placeboDRUG

Sponsors & collaborators

Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd.lead sponsor

Mapped research locations

BeijingChina1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT07394114 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.